Nanotechnology‐Based CAR‐T Strategies for Improving Efficacy and Safety of Tumor Immunotherapy
Nanotechnology‐Based CAR‐T Strategies for Improving Efficacy and Safety of Tumor Immunotherapy
复制标题
基于纳米技术的 CAR-T 策略提高肿瘤免疫治疗的疗效和安全性
DOI:
10.1002/adfm.202004713
复制
发表时间:
2020-09
影响因子:
19
通讯作者:
Liu Baorui
中科院分区:
文献类型:
--
作者:
Wang Xinyue;Meng Fanyan;Yen YingTzu;Li Rutian;Liu Baorui
Therapeutic responses to chimeric antigen receptor (CAR) T cell therapy in patients with limited treatment options have been appealing in several clinical trials. However, the efficacy of CAR‐T therapy has been challenged by several obstacles when treatin
登录
查看更多内容
影响因子:
38.3
作者:
通讯作者:
--
DOI:
10.1038/nrd.2017.243
发表时间:
2018-04
期刊:
Nature reviews. Drug discovery
影响因子:
--
作者:
Pardi N;Hogan MJ;Porter FW;Weissman D
通讯作者:
Weissman D
影响因子:
82.9
作者:
Gros A;Parkhurst MR;Tran E;Pasetto A;Robbins PF;Ilyas S;Prickett TD;Gartner JJ;Crystal JS;Roberts IM;Trebska-McGowan K;Wunderlich JR;Yang JC;Rosenberg SA
通讯作者:
Rosenberg SA
影响因子:
82.9
作者:
Giavridis T;van der Stegen SJC;Eyquem J;Hamieh M;Piersigilli A;Sadelain M
通讯作者:
Sadelain M
影响因子:
5.4
作者:
Perica, Karlo;Medero, Andres De Leon;Durai, Malarvizhi;Chiu, Yen Ling;Bieler, Joan Glick;Sibener, Leah;Niemoeller, Michaela;Assenmacher, Mario;Richter, Anne;Edidin, Michael;Oelke, Mathias;Schneck, Jonathan
通讯作者:
Schneck, Jonathan